| ▲ | ekianjo 2 hours ago | ||||||||||||||||
> seems to work very well for a potentially lethal disease not lethal for all age groups, we already knew it well before the vaccine was introduced. People may have short memories, the vaccine came almost a year after the disease was out, and we knew very well by then that it did not kill everyone, broadly. | |||||||||||||||||
| ▲ | majormajor 2 hours ago | parent | next [-] | ||||||||||||||||
> not lethal for all age groups, we already knew it well before the vaccine was introduced. People may have short memories, the vaccine came almost a year after the disease was out, and we knew very well by then that it did not kill everyone, broadly. And the vaccine wasn't trialed or rolled out initially for all age groups. One major reason was because double-blind trials were done first. For instance, here is the enrollment page for a double-blind study from 2020 for those between 18-55: https://studypages.com/s/join-a-covid-19-vaccine-research-st... This one was was 18-59: https://clinicaltrials.gov/study/NCT04582344 with two cohorts: "The first cohort will be healthcare workers in the high risk group (K-1) and the second cohort will be people at normal risk (K-2)" If you look at case rates, hospitalization load, and death rates for summer/fall/winter 2020 pre-vaccine, and compare to the load on the system in summer-2021 and later when people were far more social and active, the economy was starting to recover, then the efficacy of the vaccine was pretty obvious in letting people get out of lockdown without killing hugely more people and overwhelming the healthcare system. And it was tested pre-rollout in double-blind fashion and rolled out in a phased way to the most needy groups first, with monitoring and study of those groups. What, concretely, are you proposing should have been done differently? | |||||||||||||||||
| |||||||||||||||||
| ▲ | biophysboy an hour ago | parent | prev [-] | ||||||||||||||||
morbidity is also bad and should be prevented | |||||||||||||||||